What does this research mean for the field?

Plant-derived polymeric materials, such as polysaccharides, proteins, and gums, are effective, low-toxicity nanocarriers that improve targeted drug delivery and therapeutic outcomes for breast cancer. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review recent advances in plant-derived polymeric nanocarriers and assess their potential for targeted, low-toxicity chemotherapeutic drug delivery in breast cancer.

September 2, 2026ChemistrySelect

Sustainable Plant‐Derived Polymeric Materials‐Based Nanocarriers for Targeted Drug Delivery of Breast Cancer Therapeutics: State‐of‐the‐Art Review

View Full Paper

Ask AI

Bookmark

Authors

SKSelvaraj KunjiappanAlliance University PPParasuraman PavadaiM S Ramaiah University of Applied Sciences DMDevika Muraleedharan

Discussion

Member takes

Overview

Narrative review demonstrates plant-derived polymeric nanocarriers enhance targeted drug delivery in breast cancer, highlighting sustainable strategies to reduce toxicity.

Key Points

To review recent advances in plant-derived polymeric nanocarriers and assess their potential for targeted, low-toxicity chemotherapeutic drug delivery in breast cancer.
Synthesized literature on natural plant-derived polymers, focusing on polysaccharides, proteins, and gums utilized for nanoparticle assembly.
Evaluated physicochemical encapsulation methods for hydrophobic and hydrophilic anticancer drugs, alongside surface functionalization strategies for stimuli-triggered drug release.
Plant-derived polymers self-assemble into biocompatible nanocarriers capable of shielding chemotherapeutics from enzymatic degradation, ultraviolet light, gastric acid, and pH shifts.
Surface-modified plant biopolymer nanoparticles exhibit extended systemic circulation, selective tumor targeting, and controlled stimuli-responsive release while displaying minimal intrinsic cytotoxicity.

Cite This Study

Kunjiappan et al. (2026) studied this question.

synapsesocial.com/papers/6a97e2b1c562ede874ec6e4c https://doi.org/10.1002/slct.74002

View Full Paper

Ask AI

Bookmark

September 2, 2026ChemistrySelect

Sustainable Plant‐Derived Polymeric Materials‐Based Nanocarriers for Targeted Drug Delivery of Breast Cancer Therapeutics: State‐of‐the‐Art Review

View Full Paper

Ask AI

Bookmark

Authors

SKSelvaraj KunjiappanAlliance University PPParasuraman PavadaiM S Ramaiah University of Applied Sciences DMDevika Muraleedharan

Discussion

Member takes

Overview

Narrative review demonstrates plant-derived polymeric nanocarriers enhance targeted drug delivery in breast cancer, highlighting sustainable strategies to reduce toxicity.

Key Points

To review recent advances in plant-derived polymeric nanocarriers and assess their potential for targeted, low-toxicity chemotherapeutic drug delivery in breast cancer.
Synthesized literature on natural plant-derived polymers, focusing on polysaccharides, proteins, and gums utilized for nanoparticle assembly.
Evaluated physicochemical encapsulation methods for hydrophobic and hydrophilic anticancer drugs, alongside surface functionalization strategies for stimuli-triggered drug release.
Plant-derived polymers self-assemble into biocompatible nanocarriers capable of shielding chemotherapeutics from enzymatic degradation, ultraviolet light, gastric acid, and pH shifts.
Surface-modified plant biopolymer nanoparticles exhibit extended systemic circulation, selective tumor targeting, and controlled stimuli-responsive release while displaying minimal intrinsic cytotoxicity.

Cite This Study

Kunjiappan et al. (2026) studied this question.

synapsesocial.com/papers/6a97e2b1c562ede874ec6e4c https://doi.org/10.1002/slct.74002

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark